Benjamin Adegbite

ORCID: 0000-0002-2070-7965

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Pathological response following neoadjuvant immune checkpoint inhibitors in patients with hepatocellular carcinoma: a cross-trial, patient-level analysis”.

Pathological response following neoadjuvant immune checkpoint inhibitors in patients with hepatocellular carcinoma: a cross-trial, patient-level analysis

The Lancet Oncology(2024)10.1016/s1470-2045(24)00457-1

N/A

1.7DataRank · unranked

70 citations

Bernardo Stefanini, Julia Blanter, Benjamin Adegbite, Fionnuala Crowley, Vincent Yip +18 more

Patient-Specific Pharmacokinetics and Dasatinib Nephrotoxicity

Clinical Journal of the American Society of Nephrology(2023)10.2215/cjn.0000000000000219

N/A

0DataRank · unranked

10 citations

Matthew Abramson, Victoria Gutgarts, Florin Marcel Musteata, Kinsuk Chauhan, Alecia N. Muwonge +13 more

Dasatinib nephrotoxicity correlates with patient-specific pharmacokinetics

medRxiv(2023)10.1101/2023.04.09.23288333

N/A

0DataRank · unranked

1 citations

Matthew Abramson, Victoria Gutgarts, Marcel F. Musteata, Kinsuk Chauhan, Alecia N. Muwonge +13 more